青瓜视频

The groundbreaking discoveries come from a study delivered through the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC) and , and The University of Manchester and could provide answers for several thousands of people with neurodevelopmental conditions around the world.

Since the breakthrough, 18-year-old Rose Anderson from Stretford in Manchester has received a diagnosis of one of the newly discovered conditions.

Rose has been known to the team at the Manchester Centre for Genomic Medicine at Manchester University NHS Foundation Trust (MFT) for nearly her whole life, although a precise diagnosis for her seizures and developmental delay has proved difficult to find.

On receiving the news from the Manchester research team last year, Rose青瓜视频檚 mum Lyn said: 青瓜视频淲e felt excited and relieved to finally receive Rose青瓜视频檚 diagnosis. Rose is a very happy person, and with any diagnosis, she will always be Rose to us. This has helped us pinpoint what has caused her to be the way she is.青瓜视频�

The study was supported by the MFT-hosted NIHR Manchester BRC, as part of its which aims to improve diagnosis of rare conditions.

Researchers from the NIHR Manchester BRC, MFT, and The University of Manchester (UoM) collaborated with scientists globally to analyse the genetic data of thousands of individuals including those who took part in the a Genomics England initiative to sequence and study the role genes play in health and disease.

Genes are sections of our DNA and contain the instructions for building proteins, which are needed by the body for cell growth and repair.

Parts of our genes that do not make proteins have previously been dismissed as 青瓜视频榙ark matter青瓜视频� because they were not understood, or 青瓜视频榡unk DNA青瓜视频� because it was thought they were not essential.

Published in Nature Genetics today (date), Manchester researchers have challenged these assumptions, showing that changes in these regions play a crucial role in brain development.

The team found that mutations in regions of the genome that form R-loops (special DNA-RNA structures that can influence genetic activity) are more common than previously thought.

This insight led them to uncover two new neurodevelopmental conditions:

• RNU2-2-related disorder, which is linked to developmental delays, intellectual disability, small head size (microcephaly), autistic traits and seizures.
• RNU5B-1-related disorder, associated with developmental delays, weak muscle tone (hypotonia), larger-than-average head size (macrocephaly), and poor growth.

Neurodevelopmental conditions 青瓜视频� disorders that affect brain development 青瓜视频� impact 2-5% of people worldwide.

For many families, these conditions remain a mystery, as current genetic tests often fail to find a cause.

The two new conditions, along with ReNU syndrome (a condition identified in 2024 which has an impact on learning, behaviour, speech and movement) account for more than 1% of all unsolved developmental cases.

This means the breakthrough could provide a genetic explanation for several thousands of people globally with these conditions.

Rose, who was diagnosed with RNU2-2-related disorder in October 2024, loves music, walking, swimming, visiting cafes and riding a tandem bike. She lives with her mum Lyn, dad Joe and younger sister, Lily.

At Lyn青瓜视频檚 20-week pregnancy scan, it was first suspected that Rose may have a rare genetic condition. Despite undergoing extensive genetic testing at MFT and taking part in research, the team had been previously unable to find a specific cause for Rose青瓜视频檚 symptoms.

Lyn said: 青瓜视频淵ou wonder if it青瓜视频檚 just a random thing that has happened or parents sometimes look to themselves for the cause. Rose first started experiencing seizures when she was a baby 青瓜视频� she would become flushed, very vacant and would loll her head to one side. After a bad seizure when she was 2 and a half years old, Rose was diagnosed with epilepsy. She occasionally has seizures now, but these are better managed with medication.

青瓜视频淲hen Rose went to nursery, younger children began overtaking her with early developmental milestones. Rose is non-verbal and is great at communicating using objects and symbols. She experiences hyperventilation (rapid breathing), can struggle with spatial awareness and needs support with eating and personal care.

青瓜视频淭his breakthrough is fantastic, and we hope it will lead to more families receiving a diagnosis now and when early symptoms first appear. This could help improve quality of life for other children and young people and find out what it is that makes them unique.青瓜视频�

Rose and her family are working with the Manchester team to help them better understand RNU2-2 related disorder. Rose has also taken part in more research at MFT since receiving her diagnosis, including donating skin cells to help the team produce brain stem cells for epilepsy research.

Study lead and first author of the paper Dr Adam Jackson, Academic Clinical Fellow at the Manchester Centre for Genomic Medicine at MFT and The University of Manchester and early career researcher in the NIHR Manchester BRC青瓜视频檚 Rare Conditions Theme, said: 青瓜视频淏y proving that non-protein coding genes play a key role in human health, this study challenges long-held assumptions about 青瓜视频榡unk DNA青瓜视频� and brings hope to many families searching for answers.青瓜视频�

Dr Jackson, who is also part of the (MRCC), a virtual centre based at MFT which aims to improve the lives of people with rare conditions, explained: 青瓜视频淚dentifying these genetic mutations was a one-year process. They are difficult to understand because they are in the 青瓜视频榙ark matter青瓜视频�, so we didn青瓜视频檛 know what their effect would be when they don青瓜视频檛 produce a protein. It was thought that one of the genes didn青瓜视频檛 do anything at all, but our method of looking at R-loop forming regions has highlighted this region to be active.青瓜视频�

15-year-old Noah from the Isle of Wight was diagnosed with RNU5B-1-related disorder by the team at University Hospital Southampton NHS Foundation Trust this year, more than seven years after donating his DNA for the 100,000 Genomes Project.

His mum, Maria Villa Vine, said: 青瓜视频淲e were blown away when we received the diagnosis and to find out it was rare. I always knew my boy was special, but this confirmed it! Having a diagnosis can help you understand yourself, so this will support Noah being able to do that.青瓜视频�

Noah青瓜视频檚 diagnostic journey began at around 15 months old when his family noticed he wasn青瓜视频檛 reaching some milestones that are typically displayed at that age. At four years old, Noah was diagnosed with autistic traits and following a reassessment when he was 12, Noah was diagnosed as autistic.

Following extensive initial genetic investigations by clinicians in Southampton, Noah took part in the 100,000 Genomes Project. This did not find a diagnosis, but his data was entered into the research environment which resulted in the Manchester team青瓜视频檚 discovery.

Maria said: 青瓜视频淲e took part in the 100,000 Genomes Project because as a family we thought, what青瓜视频檚 there to lose? If it can help your child or other children with disabilities in the community, why wouldn青瓜视频檛 you? We didn青瓜视频檛 expect to hear anything from it until we got the phone call.

青瓜视频淣avigating early years as a parent can be difficult, it青瓜视频檚 full of emotion and your brain blocks things out. You can feel self-blame and guilt, wondering if it青瓜视频檚 something you did. It can also be a hard time for siblings 青瓜视频� Noah青瓜视频檚 sister was seven at the time of his autism diagnosis. It青瓜视频檚 important to have a network of professionals around families to support them and put the children at the centre of conversations.青瓜视频�

This study was supported by the , which facilitates research into the epigenomics of rare diseases and is part of the Medical Research Council and NIHR-funded Rare Diseases UK Platform.

Professor Siddharth Banka, senior author of the study who oversaw the research, is a Professor of Genomic Medicine and Rare Diseases at UoM, Consultant Clinical Geneticist at the Manchester Centre for Genomic Medicine at MFT, and Clinical Director of the MRCC.

Discussing the next steps for the research, Professor Banka, who is also the Rare Conditions Co-Theme Lead at the NIHR Manchester BRC and Co-Lead for the EpiGenRare Node, said: 青瓜视频淲e now want to understand these conditions better, such as how do their symptoms evolve over time, are there any associated complications and discover potential treatment options. We also need to understand the mechanism of the disease better 青瓜视频� how exactly are these genetic mutations causing neurodevelopmental conditions? With this information, we hope to identify treatments and therapies, and make these available for patients.青瓜视频�

The Manchester-based team青瓜视频檚 findings have also had a positive impact on patients and families worldwide.

In Australia, the breakthrough has meant that clinicians there were able to diagnose with RNU2-2-related disorder after a decade-long diagnostic journey.

Gitty青瓜视频檚 mum, Miriam, said: 青瓜视频淲e felt very relieved when we found out. The diagnosis didn青瓜视频檛 change anything because Gitty was 10 years old at this stage and we青瓜视频檝e lived through all these symptoms. But knowing that it won青瓜视频檛 affect our other children and can青瓜视频檛 be passed down by them was a big relief. Uncertainty can be very unnerving, so having a diagnosis gives us peace of mind.青瓜视频�

Professor Marian Knight, Scientific Director for NIHR Infrastructure, said: 青瓜视频淔or parents of children with neurodevelopmental conditions, understanding the cause of symptoms is an essential first step to getting the best help for their child. The experimental medicine championed by our NIHR Biomedical Research Centres which leads to important discoveries like this provides real benefits for real people like Rose. This exciting work has the potential to change the care of patients not only in the UK but around the world."

Dr Sarah Wynn, CEO of Unique, a charity which supports families affected by rare genetic disorders, said: 青瓜视频淭his research study which has discovered two new frequent causes of neurodevelopmental conditions is incredibly important and valuable to patients and families, who have often been searching for a long time for the answer to their child青瓜视频檚 developmental delays. Receiving a diagnosis like this can be life-changing for families, not only by providing the explanation they have been looking for but enabling them to connect to others and learn more about the condition resulting in improved care and support for their child. We are enormously grateful to research teams such as this, who work tirelessly to discover new gene associations and understand more about rare genetic conditions bringing benefit to people and families all over the world.青瓜视频�